Annika Dufour

2.7k citations

33 papers · 843 indexed · h-index 14

Impact in

Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 28
- Acute Myeloid Leukemia Research 27
- Chronic Myeloid Leukemia Treatments 8
- Multiple Myeloma Research and Treatments 3
Genetics 10
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Chronic Lymphocytic Leukemia Research 4

Co-authors: Karsten Spiekermann Stefan K. Bohlander Jan Braess Wolfgang Hiddemann Wolfgang E. Berdel Klaus H. Metzeler Tobias Benthaus Evelyn Zellmeier
Journals: Blood (15 papers)Blood Advances (3 papers)British Journal of Haematology (2 papers)Journal of Clinical Oncology (2 papers)Scientific Reports (1 paper)
Partner nations: Germany Netherlands United States

In The Last Decade

Annika Dufour

32 papers receiving 828 citations

Peers

Countries citing papers authored by Annika Dufour

Since Specialization

Citations

This map shows the geographic impact of Annika Dufour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika Dufour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika Dufour more than expected).

Fields of papers citing papers by Annika Dufour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annika Dufour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika Dufour. The network helps show where Annika Dufour may publish in the future.

Co-authors

The 25 scholars most cited alongside Annika Dufour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Annika Dufour Line = papers co-authored together Annika Dufour links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantation Blood Advances ·Alessia Fraccaroli, Vindi Jurinović, Klaus Hirschbühl, 贺建委, Katrin Koch, E. Aldaz, Sarah Haebe, Sonia Pouvreau, Maja Rothenberg‐Thurley, Annika Dufour, Klaus H. Metzeler, Karsten Spiekermann, Marcus Hentrich, Andreas Hausmann, Mareike Verbeek, Christoph Schmid, Tobias Herold, María Marco Cramer	2025	3
2	Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia Leukemia ·Christian Rausch, Maja Rothenberg‐Thurley, Annika Dufour, Stephanie Schneider, Tobias Fischer, Cristina Sauerland, Dennis Görlich, Utz Krug, Wolfgang E. Berdel, Bernhard J. Woermann, Wolfgang Hiddemann, Jan Braess, Michael von Bergwelt‐Baildon, Karsten Spiekermann, Tobias Herold, Klaus H. Metzeler	2023	45
3	Double Drop-Off Droplet Digital PCR Journal of Molecular Diagnostics ·Christian Rausch, Maja Rothenberg‐Thurley, Kai Jun Chew, Hatice Polat, Annika Dufour, Michaela Neusser, Stephanie Schneider, Karsten Spiekermann, Klaus H. Metzeler, Frank Ziemann	2021	18
4	Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA Blood Advances ·Nikola P. Konstandin, Friederike Pastore, Tobias Herold, Annika Dufour, Maja Rothenberg‐Thurley, Tanja Hinrichsen, Bianka Ksienzyk, Hatice Polat, Stephanie Schneider, Eva Hoster, Wolfgang E. Berdel, Bernhard J. Woermann, Maria C. Sauerland, Jan Braess, Stefan K. Bohlander, Hanns‐Georg Klein, Wolfgang Hiddemann, Klaus H. Metzeler, Karsten Spiekermann	2018	38
5	Combination of t(4;14), del(17p13), del(1p32) and 1q21 gain FISH probes identifies clonal heterogeneity and enhances the detection of adverse cytogenetic profiles in 233 newly diagnosed multiple myeloma Molecular Cytogenetics ·Thomas Smol, Annika Dufour, Sabine Tricot, Mathieu Wémeau, Biamah K. Philip, Franck Bernardi, Christine Terré, Amanda Matias Cavalcante de Oliveira Pessoa, Mbusi Dlamini, Agnès Daudignon	2017	13
6	The new and recurrent FLT3 juxtamembrane deletion mutation shows a dominant negative effect on the wild-type FLT3 receptor Scientific Reports ·Hao Wu, Julia Bauer, Katrin Reiter, Annika Dufour, T. Lacornerie, Nikola P. Konstandin, Evelyn Zellmeier, ICHIJI ITOH, Philipp A. Greif, Klaus H. Metzeler, Wolfgang Hiddemann, Harald Polzer, Karsten Spiekermann	2016	10
7	Young woman with mild bone marrow dysplasia, GATA2 and ASXL1 mutation treated with allogeneic hematopoietic stem cell transplantation Leukemia Research Reports ·Anna Lübking, Sebastian Vosberg, Nikola P. Konstandin, Annika Dufour, Alexander Graf, Stefan Krebs, Helmut Blum, Axel Weber, Stig Lenhoff, Mats Ehinger, Karsten Spiekermann, Philipp A. Greif, Jörg Cammenga	2015	11
8	Long-term follow-up of cytogenetically normal CEBPA-mutated AML Journal of Hematology & Oncology ·Friederike Pastore, Udo Rheude, Eva Hoster, Annika Dufour, Nikola P. Konstandin, Stephanie Schneider, Maria Cristina Sauerland, Wolfgang E. Berdel, Thomas Buechner, Bernhard J. Woermann, Jan Braess, Wolfgang Hiddemann, Karsten Spiekermann	2014	34
9	Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients Annals of Hematology ·(unknown), Annika Dufour, Friederike Schneider, Eva Hoster, Tobias Benthaus, Bianka Ksienzyk, Stephanie Schneider, Purvi M. Kakadia, Maria‐Cristina Sauerland, Wolfgang E. Berdel, Thomas Büchner, Bernhard Wörmann, Jan Braess, Marion Subklewe, Wolfgang Hiddemann, Stefan K. Bohlander, Karsten Spiekermann	2012	27
10	High expression ofMZB1predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature Leukemia & lymphoma ·Tobias Herold, Medhanie Mulaw, Vindi Jurinović, Till Seiler, Klaus H. Metzeler, Annika Dufour, Stephanie Schneider, Purvi M. Kakadia, Karsten Spiekermann, Ulrich Mansmann, Wolfgang Hiddemann, Christian Buske, Martin Dreyling, Stefan K. Bohlander	2012	23
11	High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia Blood ·Klaus H. Metzeler, Bernhard Heilmeier, Maria Claudia Aguitoni, Vijay P.S. Rawat, Annika Dufour, Konstanze Döhner, Michaela Feuring‐Buske, Jan Braess, Karsten Spiekermann, Thomas Büchner, Maria Cristina Sauerland, Hartmut Döhner, Wolfgang Hiddemann, Stefan K. Bohlander, Richard F. Schlenk, Lars Bullinger, Christian Buske	2012	54
12	Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22‐23 in chronic lymphocytic leukemia—unexpected expression pattern of the RHO GTPase activator ARHGAP20 Genes Chromosomes and Cancer ·Tobias Herold, Vindi Jurinović, Medhanie Mulaw, Till Seiler, Annika Dufour, Stephanie Schneider, Purvi M. Kakadia, Michaela Feuring‐Buske, Jan Braess, Karsten Spiekermann, Ulrich Mansmann, Wolfgang Hiddemann, Christian Buske, Stefan K. Bohlander	2011	13
13	Identification of Recurring Tumor-Specific Somatic Mutations In Acute Myeloid Leukemia by Transcriptome Sequencing. Blood ·Philipp A. Greif, Sebastian Eck, Nikola P. Konstandin, Anna Benet‐Pagès, Annika Dufour, Anna Vetter, Henning D. Popp, Bettina Lorenz‐Depiereux, Thomas Meitinger, Stefan K. Bohlander, Tim M. Strom	2010	2
14	Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome Journal of Clinical Oncology ·Annika Dufour, Friederike Schneider, Klaus H. Metzeler, Eva Hoster, Stephanie Schneider, Evelyn Zellmeier, Tobias Benthaus, Maria‐Cristina Sauerland, Wolfgang E. Berdel, Thomas Büchner, Bernhard Wörmann, Jan Braess, Wolfgang Hiddemann, Stefan K. Bohlander, Karsten Spiekermann	2009	189
15	NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS) Blood ·Friederike Schneider, Eva Hoster, Michael Unterhalt, Stephanie Schneider, Annika Dufour, Tobias Benthaus, Gudrun Mellert, C. Mpofu, Stefan K. Bohlander, Michaela Feuring‐Buske, Christian Buske, Jan Braess, Susanne Fritsch, Achim Heinecke, Maria Cristina Sauerland, Wolfgang E. Berdel, Thomas Buechner, Bernhard J. Woermann, Wolfgang Hiddemann, Karsten Spiekermann	2009	48
16	ERG Expression Is an Independent Prognostic Factor and Allows Refined Risk Stratification in Cytogenetically Normal Acute Myeloid Leukemia: A Comprehensive Analysis of ERG, MN1, and BAALC Transcript Levels Using Oligonucleotide Microarrays Journal of Clinical Oncology ·Klaus H. Metzeler, Annika Dufour, Tobias Benthaus, Manuela Hummel, Maria‐Cristina Sauerland, Achim Heinecke, Wolfgang E. Berdel, Thomas Büchner, Bernhard Wörmann, Ulrich Mansmann, Jan Braess, Karsten Spiekermann, Wolfgang Hiddemann, Christian Buske, Stefan K. Bohlander	2009	90
17	Rapid and sensitive screening for CEBPA mutations in acute myeloid leukaemia British Journal of Haematology ·Tobias Benthaus, Friederike Schneider, Gudrun Mellert, Evelyn Zellmeier, Stephanie E. Schneider, Purvi M. Kakadia, Wolfgang Hiddemann, Stefan K. Bohlander, Michaela Feuring‐Buske, Jan Braess, Karsten Spiekermann, Annika Dufour	2008	45
18	Age-Dependent Frequencies of NPM-1/FLT3-ITD Mutations in Patients with Normal Karyotype AML Blood ·Friederike Schneider, Eva Hoster, Michael Unterhalt, Stephanie Schneider, Annika Dufour, Tobias Benthaus, Gudrun Mellert, Evelyn Zellmeier, Stefan K. Bohlander, Michaela Feuring‐Buske, Christian Buske, Jan Braess, Achim Heinecke, Maria C. Sauerland, Wolfgang E. Berdel, Thomas Buechner, Wolfgang Hiddemann, Karsten Spiekermann	2008	3
19	Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor British Journal of Haematology ·P. Belder, Annika Dufour, Ahmad Musawwir Azhim, Stephanie Schneider, Stefan K. Bohlander, Evelyn Zellmeier, Gudrun Mellert, Wolfgang Hiddemann, Karsten Spiekermann	2008	59
20	A Rapid and Sensitive Method for Large-Scale Screening of CEBPA Mutations in AML Patients with Normal Karyotype. Blood ·Tobias Benthaus, Gudrun Mellert, Evelyn Zellmeier, Wolfgang Hiddemann, Karsten Spiekermann, Annika Dufour	2007	1

About Annika Dufour

Annika Dufour is a scholar working on Hematology, Genetics, Cancer Research, Molecular Biology and Oncology, having authored 33 papers that have together received 843 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (27 papers), Chronic Myeloid Leukemia Treatments (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Protein Degradation and Inhibitors (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Cancer Genomics and Diagnostics (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Hematology (656 citations), Genetics (253 citations), Cancer Research (128 citations), Molecular Biology (414 citations) and Public Health, Environmental and Occupational Health (154 citations). Annika Dufour has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Karsten Spiekermann, Stefan K. Bohlander, Jan Braess, Wolfgang Hiddemann, Wolfgang E. Berdel, Klaus H. Metzeler, Tobias Benthaus, Evelyn Zellmeier, Thomas Büchner and Eva Hoster. Their work appears in journals such as Blood, Blood Advances, British Journal of Haematology, Journal of Clinical Oncology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact